Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86

1.

Recent progress in the diagnosis and treatment of ovarian cancer.

Jelovac D, Armstrong DK.

CA Cancer J Clin. 2011 May-Jun;61(3):183-203. doi: 10.3322/caac.20113. Epub 2011 Apr 26.

PMID:
21521830
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Advances in the management of epithelial ovarian cancer.

Berkenblit A, Cannistra SA.

J Reprod Med. 2005 Jun;50(6):426-38. Review.

PMID:
16050567
[PubMed - indexed for MEDLINE]
3.

Surgical cytoreduction for recurrent epithelial ovarian cancer.

Al Rawahi T, Lopes AD, Bristow RE, Bryant A, Elattar A, Chattopadhyay S, Galaal K.

Cochrane Database Syst Rev. 2013 Feb 28;2:CD008765. doi: 10.1002/14651858.CD008765.pub3. Review.

PMID:
23450588
[PubMed - indexed for MEDLINE]
4.

Prevention and early detection of ovarian cancer: mission impossible?

Bast RC Jr, Brewer M, Zou C, Hernandez MA, Daley M, Ozols R, Lu K, Lu Z, Badgwell D, Mills GB, Skates S, Zhang Z, Chan D, Lokshin A, Yu Y.

Recent Results Cancer Res. 2007;174:91-100. Review.

PMID:
17302189
[PubMed - indexed for MEDLINE]
5.

[The molecular biology of epithelial ovarian cancer].

Leary A, Pautier P, Tazi Y, Morice P, Duvillard P, Gouy S, Uzan C, Gauthier H, Balleyguier C, Lhommé C.

Bull Cancer. 2012 Dec;99(12):1161-73. doi: 10.1684/bdc.2012.1667. Review. French.

PMID:
23238064
[PubMed - indexed for MEDLINE]
6.

Recent advances in the management of women with ovarian cancer.

Eltabbakh GH.

Minerva Ginecol. 2004 Feb;56(1):81-9. Review.

PMID:
14973412
[PubMed - indexed for MEDLINE]
7.

Gynecological malignancies.

Schaebler DL, Schilder RJ, Young RC.

Cancer Chemother Biol Response Modif. 1996;16:564-91. Review.

PMID:
8639401
[PubMed - indexed for MEDLINE]
8.

The potential for risk stratification in the management of ovarian cancer risk.

Pharoah PD.

Int J Gynecol Cancer. 2012 May;22 Suppl 1:S16-7. doi: 10.1097/IGC.0b013e318251caaf. Review.

PMID:
22543912
[PubMed - indexed for MEDLINE]
9.

Recent advances in the treatment of epithelial ovarian cancer.

Harries M, Kaye SB.

Expert Opin Investig Drugs. 2001 Sep;10(9):1715-24. Review.

PMID:
11772280
[PubMed - indexed for MEDLINE]
10.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
[PubMed - indexed for MEDLINE]
11.

Medical therapy of advanced malignant epithelial tumours of the ovary.

Colombo N, Parma G, Bocciolone L, Franchi D, Sideri M, Maggioni A.

Forum (Genova). 2000 Oct-Dec;10(4):323-32. Review.

PMID:
11535983
[PubMed - indexed for MEDLINE]
12.

[Epithelial ovarian cancer - a change of paradigm].

Heinzelmann-Schwarz V.

Ther Umsch. 2011 Oct;68(10):565-72. doi: 10.1024/0040-5930/a000215. Review. German.

PMID:
21968896
[PubMed - indexed for MEDLINE]
13.

Diagnosis and management of epithelial ovarian cancer.

Bhoola S, Hoskins WJ.

Obstet Gynecol. 2006 Jun;107(6):1399-410. Review.

PMID:
16738170
[PubMed - indexed for MEDLINE]
14.

Biomarker discovery in epithelial ovarian cancer by genomic approaches.

Mok SC, Elias KM, Wong KK, Ho K, Bonome T, Birrer MJ.

Adv Cancer Res. 2007;96:1-22. Review.

PMID:
17161674
[PubMed - indexed for MEDLINE]
15.

Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.

Winter-Roach BA, Kitchener HC, Lawrie TA.

Cochrane Database Syst Rev. 2012 Mar 14;3:CD004706. doi: 10.1002/14651858.CD004706.pub4. Review.

PMID:
22419298
[PubMed - indexed for MEDLINE]
16.

Ovarian cancer: epidemiology, biology, and prognostic factors.

Holschneider CH, Berek JS.

Semin Surg Oncol. 2000 Jul-Aug;19(1):3-10. Review.

PMID:
10883018
[PubMed - indexed for MEDLINE]
17.

Clinical trials and future potential of targeted therapy for ovarian cancer.

Itamochi H, Kigawa J.

Int J Clin Oncol. 2012 Oct;17(5):430-40. doi: 10.1007/s10147-012-0459-8. Epub 2012 Aug 28. Review.

PMID:
22926640
[PubMed - indexed for MEDLINE]
18.

[Epithelial ovarian cancer].

Hilpert F, Krause G, Venhoff L, Kühnle E, Schem C, Maass N.

Ther Umsch. 2007 Jul;64(7):375-80. Review. German.

PMID:
17948754
[PubMed - indexed for MEDLINE]
19.

Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.

Winter-Roach BA, Kitchener HC, Dickinson HO.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD004706. doi: 10.1002/14651858.CD004706.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;3:CD004706.

PMID:
19588360
[PubMed - indexed for MEDLINE]
20.

PARP inhibitors and epithelial ovarian cancer: an approach to targeted chemotherapy and personalised medicine.

Mukhopadhyay A, Curtin N, Plummer R, Edmondson RJ.

BJOG. 2011 Mar;118(4):429-32. doi: 10.1111/j.1471-0528.2010.02838.x. Epub 2011 Jan 18. Review.

PMID:
21244617
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk